The global infusion pumps market is expected to grow at a CAGR of ~8.8% from 2021 to reach ~22.06 billion by 2027. The growth is primarily attributed to prevalence of chronic diseases, increasing geriatric population, rising demand for infusion pumps and increasing number of surgeries performed across the globe. However, regulatory scenario and errors associated with infusion pumps and growing trends of refurbished infusion pumps are expected to hinder the growth of this market. Rising demand of specialized infusion pumps and growth potentials in emerging countries offer significant growth opportunities.
By Accessories and Consumables: Insulin infusion pumps to register highest CAGR
Insulin infusion pumps segment is anticipated to register highest CAGR during the forecast period. The growth of this market segment can be attributed to prevalence of diabetes, ease of use owing to self-administration, low chances of error and replacement of multiple daily injections. In addition, growing development of user-friendly devices is further expected to drive the growth of this market.
By Devices: Volumetric infusion pumps dominated the infusion pump market in 2020
Based on devices, volumetric infusion pump segment accounted for the largest share of infusion pumps market in 2020. The large share of this market segment can be attributed to capability of delivering fluids, blood or total parental nutrition to patients at a predetermined rate.
By Application: Chemotherapy/Oncology segment accounted for largest share in 2020
Based on Application, Chemotherapy/Oncology segment accounted for the largest share of infusion pumps market in 2020. The large share of this segment can be ascribed by prevalence of cancer, technological advancement and availability of infusion pumps for chemotherapy.
By setting: Hospitals to dominate global infusion pump market
Based on setting, Hospitals commanded largest share of global infusion pump market in 2020. The large share of this market segment can be attributed to high purchasing power of hospitals, large patient pool and availability of trained professionals. Home care setting is expected to grow at highest CAGR during forecast period due to government initiatives to reduce healthcare costs.
By Region: Asia Pacific is expected to grow at a fastest rate
In 2020, North America accounted for the largest share of infusion pumps market. The largest share is mainly attributed to high adoption, prevalence of chronic diseases, growing geriatric population and highly developed healthcare infrastructure. However, Asia Pacific region is expected to grow at fastest CAGR during the forecast period. The growth is driven by increasing burden of cancer and diabetes in Asian countries, rising adoption of infusion pumps and increasing number of surgeries performed in these countries.
Competitive Scenario
Becton Dickinson and Company (US)
Baxter International (US)
B. Braun (Germany)
ICU Medical (US)
Fresenius Kabi (Germany)
Smiths Medical (US)
Medtronic PLC (Ireland)
And Moog Inc. (US)
are the key players operating in this market.
Other players are
Avanos Medical Inc. (US)
Nipro Corporation (Japan)
Terumo Corporation (Japan)
Insulet Corporation (US)
Ypsomed Holding AG (Switzerland)
Tandem Diabetes Care (US)
JMS Co. Ltd. (Japan)
Micrel Medical Devices SA (Greece)
InfuTronix Solutions LLC (US)
Zyno Medical LLC (US)
Roche Diagnostics (Switzerland)
Teleflex Inc. (US)
Mindray Medical International Limited (China)
Epic Medical (Singapore)
SOOIL Development Co. Ltd. (South Korea)
Shenzhen MedRena Biotech Co. Ltd. (China)
And CODAN Medizinische Geräte GmbH & Co KG (Germany).
'
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Infusion Pumps Market
5. Industry Insights
5.1. Introduction
5.2. Industry Trends
6. Global Infusion Pumps Market, By Accessories and Consumables , 2019-2027 (USD Million)
6.1. Dedicated Accessories and Consumables
6.1.1. Volumetric infusion pumps
6.1.2. Syringe infusion pumps
6.1.3. Insulin infusion pumps
6.1.4. Enteral infusion pumps
6.1.5. Ambulatory infusion pumps
6.1.6. Patient-controlled analgesia infusion pumps
6.1.7. Implantable infusion pumps
6.2. Non- Dedicated Accessories and Consumables
6.2.1. Infusion Catheters
6.2.2. IV/administration Sets
6.2.3. Needleless Connectors
6.2.4. Cannulas
6.2.5. Tubing & Extension Sets
6.2.6. Valves
6.2.7. Other Non- Dedicated Accessories and Consumables
7. Global Infusion Pumps Market, By Device, 2019-2027 (USD Million)
7.1. By Product
7.1.1. Volumetric Infusion Pumps
7.1.2. Insulin Pumps
7.1.3. Enteral Infusion Pumps
7.1.4. Syringe Infusion Pumps
7.1.5. Ambulatory Infusion Pumps
7.1.6. PCA Pumps
7.1.7. Implantable Infusion Pumps
7.2. By Technology
7.2.1. Traditional Infusion Pumps
7.2.2. Specialty Infusion Pumps
7.3. By Type
7.3.1. Stationary Infusion Pumps
7.3.2. Portable Infusion Pumps
8. Global Infusion Pumps Market, By Application, 2019-2027 (USD Million)
8.1. Chemotherapy/Oncology
8.2. Diabetes Management
8.3. Gastroenterology
8.4. Pain Management/ Analgesia
8.5. Pediatrics/Neonatology
8.6. Hematology
8.7. Other Applications
9. Global Infusion Pumps Market, By Setting, 2019-2027 (USD Million)
9.1. Hospitals
9.2. Home care settings
9.3. Ambulatory Care Setting
9.4. Academic and Research Institutes
10. Global Infusion Pumps Market, By Geography, 2019-2027 (USD Million)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Latin America
10.4.2. Middle East & Africa
11. Competitive Landscape
11.1. Introduction
11.2. Market Share Analysis, By Key Players (2020)
11.3. Competitive Situation and Trends
11.3.1. Product Launches
11.3.2. Partnerships, Collaborations and Agreements
11.3.3. Acquisitions
11.3.4. Expansions
11.3.5. Other Developments
12. Company Profiles
12.1. Becton, Dickinson and Company (US)
12.2. Baxter International (US)
12.3. B. Braun (Germany)
12.4. ICU Medical (US)
12.5. Fresenius Kabi (Germany)
12.6. Smiths Medical (US)
12.7. Medtronic PLC (Ireland)
12.8. Moog Inc. (US)
12.9. Avanos Medical, Inc. (US)
12.10. Nipro Corporation (Japan)
12.11. Terumo Corporation (Japan)
12.12. Insulet Corporation (US)
12.13. Ypsomed Holding AG (Switzerland)
12.14. Tandem Diabetes Care (US)
12.15. JMS Co., Ltd. (Japan)
12.16. Micrel Medical Devices SA (Greece)
12.17. InfuTronix Solutions LLC (US)
12.18. Zyno Medical LLC (US)
12.19. Roche Diagnostics (Switzerland)
12.20. Teleflex, Inc. (US)
12.21. Mindray Medical International Limited (China)
12.22. Epic Medical (Singapore)
12.23. SOOIL Development Co., Ltd. (South Korea)
12.24. Shenzhen MedRena Biotech Co., Ltd. (China)
12.25. CODAN Medizinische Geräte GmbH & Co KG (Germany).
13. Appendix
